Brazil battles Chinese red tape to get active vaccine ingredients

20/1/2021 13:23

        Brazil is battling bureaucracy in China to free up exports of active ingredients for vaccines developed by AstraZeneca and Sinovac Biotech, three people
        familiar with talks told Reuters, without which an immunization push could soon slow to a trickle.
        
        More Brazilian states gave their first COVID-19 vaccinations on Tuesday, as the government distributed some 6 million ready doses of the vaccine from China's Sinovac after its approval on Sunday for emergency use.
        
        However the sources, who spoke anonymously due to diplomatic sensitivities, said red tape in China was holding back supplies needed for Brazil to finish and distribute millions more doses from its own biomedical facilities.